2017
DOI: 10.1016/j.juro.2017.02.2002
|View full text |Cite
|
Sign up to set email alerts
|

Mp65-08 Heat-Targeted Drug Delivery Using the Combat BRS Device for Treating Bladder Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…In a recent conference abstract, the results of the Combat BRS device for C-HT in pigs were described. In this in-vivo study, C-HT was able to heat the bladder lumen to a temperature of 42.9 ± 0.14 C and generated a transmural gradient of 1.5 C across the detrusor, resulting in full thickness bladder heating of >41 C [27]. However, no comparison with RF-HT was made, and no information on the inflow temperature of the C-HT was given.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…In a recent conference abstract, the results of the Combat BRS device for C-HT in pigs were described. In this in-vivo study, C-HT was able to heat the bladder lumen to a temperature of 42.9 ± 0.14 C and generated a transmural gradient of 1.5 C across the detrusor, resulting in full thickness bladder heating of >41 C [27]. However, no comparison with RF-HT was made, and no information on the inflow temperature of the C-HT was given.…”
Section: Discussionmentioning
confidence: 98%
“…In two other studies, the bladder tissue temperatures associated with the heating techniques used in this study were examined [26,27]. In a recent conference abstract, the results of the Combat BRS device for C-HT in pigs were described.…”
Section: Discussionmentioning
confidence: 99%
“…In a swine model, Thermodox is able to achieve doxorubicin levels far exceeding free doxorubicin while minimizing toxicity in other organs. 68…”
Section: Safetymentioning
confidence: 99%